Latest news
The OncFive: Top Oncology Articles for the Week of 8/2 - onclive.comonclive.com · Sat, 08 Aug 2026 10:13:24 GMTRiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - manilatimes.netmanilatimes.net · Sat, 08 Aug 2026 08:04:32 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMTProscia Wins FDA Clearance to Expand Concentriq AP-Dx Interoperability - Lab ManagerLab Manager · Fri, 07 Aug 2026 17:54:24 GMTFDA sets advisory panel for Galleri multicancer screening test - MedTech DiveMedTech Dive · Fri, 07 Aug 2026 17:39:34 GMTFDA Grants Accelerated Approval to Replimune's Tudriqev Plus Nivolumab for Advanced Melanoma - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 17:19:39 GMTEyeWorld Weekly, August 7, 2026 - EyeWorldEyeWorld · Fri, 07 Aug 2026 16:04:01 GMTFDA approves Takeda’s first-in-class narcolepsy drug - EMJEMJ · Fri, 07 Aug 2026 15:12:52 GMT